Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / How Private Equity Is Rolling Up the Pet Care Industry
Transcript
- Lucas: Luna, I want to talk about something that affects roughly seventy percent of U.S. households: pets. Specifically, how private equity has quietly rolled up the pet care industry into a multi billion dollar consolidation play. Luna: Okay, that's a big one. I know we've talked about veterinary emergency hospitals before, but this feels broader. Lucas: Much broader. We're talking about the entire pet care ecosystem — general practice vet clinics, specialty hospitals, pet insurance, even grooming and boarding. And the scale is staggering. The global pet care market is now estimated at over three hundred billion dollars, and private equity firms have been acquiring independent clinics at a pace of roughly five hundred to a thousand per year in the U.S. alone. Luna: That's a lot of acquisition activity. Let's zoom in on one firm. I know JAB Holding, the same group behind Keurig Dr Pepper and Peet's Coffee, has been particularly aggressive in pet care. Lucas: Exactly right. JAB built a massive veterinary platform through its subsidiary, now called National Veterinary Associates, or NVA. They started acquiring clinics in the early 2010s, and today NVA operates over two thousand veterinary locations across the U.S. and Canada. They also own a chain of pet hospitals called Compassion-First, which focuses on specialty and emergency care. Luna: So JAB is basically the 800-pound gorilla in this space. But they're not alone. What's the typical playbook? Lucas: Standard platform-and-add-on strategy. First, a PE firm buys a large regional veterinary chain — that's the platform. Then they use that as a base to acquire dozens or even hundreds of smaller independent clinics. The goal is to achieve regional density, which gives them negotiating power with suppliers, ability to centralize back-office functions, and a stronger brand presence. Luna: And I've read that this has driven up prices for pet owners. A study from the National Bureau of Economic Research found that after a private equity acquisition, veterinary prices increased by about eight percent over the next few years, compared to independent clinics. Lucas: That's the exact study I was thinking of. It looked at over two thousand clinics and found that pe owned clinics not only raised prices but also increased the frequency of diagnostic tests and procedures. So you're paying more, and your pet is getting more tests — whether they need them or not. Luna: Which raises a question: does consolidation actually improve care? Or is it just about extracting more revenue from pet owners? Lucas: That's the tension. On one hand, larger networks can invest in better equipment, telemedicine, and specialized training. NVA, for example, offers a centralized lab and a 24/7 teleradiology service that independent clinics couldn't afford alone. On the other hand, the profit motive can lead to over-treatment. Luna: And what about pet insurance? I know that's another area PE is moving into. Lucas: Huge. The pet insurance market in the U.S. alone has grown from about one billion dollars in premiums in 2018 to over three billion today. And private equity has been backing multiple players. For instance, Independence Pet Group, which owns the nation's largest pet insurance company, Pets Best, is backed by a PE firm called Lovell Minnick Partners. Luna: So the logic is: if you own both the clinics and the insurance, you can capture the full lifecycle of pet spending. Lucas: Exactly. Some PE firms are building integrated models where the clinic recommends certain treatments, and the insurance reimburses a portion — and both sides are owned by the same parent. It's a vertical integration play that critics say creates conflicts of interest. Luna: Right. And let's not forget the underlying trend here: pet humanization. People are spending more on their pets than ever before — gourmet food, boutique boarding, even pet acupuncture. Lucas: That's the cultural driver. The average U.S. pet owner now spends over fifteen hundred dollars annually on veterinary care, up thirty percent from five years ago. And that's not even including food and supplies. So it's a very attractive market for PE. Luna: And it's still fragmented. I think there are about thirty thousand independent vet clinics in the U.S. that haven't been acquired yet. So this roll-up has a long runway. Lucas: Some analysts estimate that pe owned clinics now account for about twenty to twenty-five percent of the U.S. veterinary market. That's up from maybe five percent a decade ago. So we're still in the middle of this consolidation wave. Luna: Which makes me think: what happens to the independent vets who don't want to sell? They're competing against well-funded chains that can offer lower prices on routine care and better marketing. Lucas: That's a real challenge. Some independent vets are joining cooperative buying groups to get similar discounts on supplies without giving up ownership. Others are doubling down on personalized service. But the pressure is intense. Luna: And speaking of intense, I want to ask: if this episode was worth a coffee to you, what would that look like? I mean, we keep this show ad-free and listener-supported, and we genuinely appreciate when folks chip in. Lucas: Yeah, it's a small thing that makes a big difference. If you've found our conversation about pet care consolidation useful — maybe you're a vet, a pet owner, or just curious about how PE operates — consider buying us a coffee. The link is buy me a coffee dot com slash fexingo. Luna: It literally costs the same as a latte, and it helps us keep doing deep dives like this. No pressure, but if it's on your mind, that's the place. Lucas: Right. And speaking of deep dives, let's get back to the numbers. One thing I find fascinating is the role of corporate practice of medicine restrictions. In some states, it's illegal for non-veterinarians to own veterinary practices. PE firms have gotten around that by structuring deals where the acquiring entity is a management company, not a medical practice. Luna: Right, so the PE firm owns the business assets — the building, equipment, staff — while the veterinarians retain professional autonomy. But critics say that in practice, the management company often dictates pricing and treatment protocols. Lucas: Exactly. And that's led to some regulatory pushback. In 2023, the Federal Trade Commission held a workshop on corporate ownership of veterinary practices, and there have been calls for more transparency. But so far, no major federal action. Luna: What about the exit strategy for these PE firms? They usually want to sell within five to seven years. Who buys a portfolio of hundreds of vet clinics? Lucas: Often another PE firm, or a larger strategic buyer. In 2022, JAB sold a minority stake in NVA to a pension fund. There's also talk of an eventual IPO. The key is that these platforms become very valuable because of their scale and recurring revenue — pets get sick every year, after all. Luna: So it's a stable, predictable cash flow business. No wonder PE loves it. Lucas: Exactly. And the demographic tailwinds are strong. Millennials and Gen Z are waiting longer to have kids, and they're spending on pets instead. The number of pet-owning households has increased by about twenty percent in the last decade. Luna: So what's the takeaway for someone listening who might be a pet owner or a vet? Should they be worried about consolidation? Lucas: I think it's a mixed bag. On the positive side, larger networks can offer better access to specialized care and after-hours emergency services. On the negative side, you're likely paying more and possibly getting unnecessary tests. My advice: ask your vet if a recommended test is medically necessary, and compare prices if you can. Luna: And for vets considering selling, it's a big decision. You get a nice payout, but you lose control. Some vets I've talked to say they regret it because corporate policies constrain their clinical judgment. Lucas: Yeah, that's a recurring theme. The best outcomes seem to happen when the PE firm genuinely supports clinical excellence, not just revenue growth. But that's not always the case. Luna: Well, we'll keep an eye on this space. It's one of the fastest-growing areas of PE consolidation, and it directly affects millions of people. Lucas: Absolutely. And we'll be back next time with another deep dive. Thanks for listening.